DEFINITIVE CONTRACT
Active75F40126C00208
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$919K
obligated · signed 1 week ago
A HIGH-THROUGHPUT PHYSIOLOGY TOOL FOR NAMS-BASED SAFETY STUDIES
Performance timeline
Start
Sep 30, 2026
End
Sep 29, 2029
with all options
Loading status
Estimated start: Sep 29, 2028
DIAGNOSTIC BIOCHIPS, INC.
Contract 75F40126C00208
UEI
PF2EA6V5G9E3
Parent Company
DIAGNOSTIC BIOCHIPS, INC.
Capabilities & Certifications
Headquarters Location
Congressional District: 03
Current Obligation
$918,951
Base + Exercised Options
$918,951
Total Ceiling Value
$918,951
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
NAICS
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
PSC
GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH
Place of Performance
Congressional District: 03
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Solicitation procedures, competition exceptions, labor standards and account totals.